There are currently two possible alternatives for the treatment of microbial infections in marine and freshwater fish: prophylactic and therapeutic. Both methods present several disadvantages, such as high equipment and labor costs, depression of the fish's immune system, causing low vaccine response and potential risk in generating microbial resistance. In view of this, the present technology represents a promising alternative in the treatment of bacterioses in aquatic organisms, presenting excellent rates of protection and survival of the species, eliminating the disadvantages presented by the other methods.
The production of nutraceutical feeds containing polyclonal antibodies IgY presents low cost, is easily administered and can be produced on an industrial scale, being inserted in the productive chains of mariculture and fish farming.
Agência Unesp de Inovação
Tel: +55 11 5627.0696